论文部分内容阅读
目的:观察乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果。方法:抽取2012年6月-2014年12月在我院就诊的60例重症急性胰腺炎患者,按随机数字表法分为观察组与对照组,各30例;观察组给予乌司他丁联合奥曲肽治疗,对照组给予奥曲肽进行治疗,比较两组患者治疗效果。结果:观察组和对照组治疗的总有效率分别为96.67%和63.33%,组间比较,差异具有统计学意义(P<0.05)。观察组患者治疗后血清以及尿淀粉酶的阳性比例明低优于对照组,组间比较,差异具有统计学意义(P<0.05)。结论:乌司他丁联合奥曲肽治疗重症急性胰腺炎疗效显著,有效改善患者的血尿淀粉酶水平,改善患者的生活质量。
Objective: To observe the clinical effect of ulinastatin combined with octreotide in the treatment of severe acute pancreatitis. Methods: Sixty patients with severe acute pancreatitis who were treated in our hospital from June 2012 to December 2014 were randomly divided into observation group and control group according to random number table method, 30 cases each. The observation group was given ulinastatin Octreotide treatment, the control group was treated with octreotide, the treatment effect of two groups were compared. Results: The total effective rates of the observation group and the control group were 96.67% and 63.33%, respectively. The differences between the two groups were statistically significant (P <0.05). The positive rate of serum and urine amylase in the observation group was lower than that of the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Ulinastatin combined with octreotide has a significant therapeutic effect on severe acute pancreatitis, effectively improving the level of hematuria and amylase in patients and improving the quality of life of patients.